Osteoporosis Treatment and Prevention for Postmenopausal Women: Current and Future Therapeutic Options

被引：28

作者：

Pinkerton, Joann V. ^{[1
]}

Thomas, Semara ^{[1
]}

Dalkin, Alan C. ^{[2
]}

机构：

[1] Univ Virginia Hlth Syst, Dept Obstet & Gynecol, Div Midlife Hlth Ctr, Charlottesville, VA USA

[2] Univ Virginia Hlth Syst, Dept Med, Div Endocrinol & Metab, Charlottesville, VA USA

来源：

CLINICAL OBSTETRICS AND GYNECOLOGY | 2013年 / 56卷 / 04期

关键词：

osteoporosis; bisphosphonates; raloxifene; teriparatide; bazedoxifene; denosumab; BONE-MINERAL DENSITY; MESENCHYMAL STEM-CELLS; BREAST-CANCER; ZOLEDRONIC ACID; RISK; FRACTURE; RALOXIFENE; TRIAL; BAZEDOXIFENE; TERIPARATIDE;

D O I：

10.1097/GRF.0b013e3182a9fb02

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Osteoporosis, a silent disease, is often unrecognized until fracture. Lifestyle modification with nutritional counseling is recommended during menopausal transition. Bone density testing is recommended for women aged 65 years and older, younger postmenopausal women with risk factors, or to follow therapy. Bisphosphonates treat osteoporosis (prevent bone resorption). Raloxifene and hormone therapy prevent bone loss and fracture, with extraskeletal benefits. Denosumab treats osteoporosis, although bone effects reverse rapidly. Teriparatide (anabolic therapy) is considered for women at high risk of fracture. Bazedoxifene with conjugated estrogens, novel delivery of teriparatide, new parathyroid hormone proteins, anti-sclerostin antibodies, cathepsin K inhibitors, and stem cell therapies are in testing.

引用

页码：711 / 721

页数：11

共 38 条

[1] The US Postmarketing Surveillance Study of Adult Osteosarcoma and Teriparatide: Study Design and Findings From the First 7 Years [J].

Andrews, Elizabeth B. ;

Gilsenan, Alicia W. ;

Midkiff, Kirk ;

Sherrill, Beth ;

Wu, Yun ;

Mann, Beth H. ;

Masica, Daniel .

JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (12) :2429-2437

[2]

[Anonymous], Clinician's Guide to Prevention and Treatment of Osteoporosis

[3]

[Anonymous], **NON-TRADITIONAL**

[4] The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) [J].

Black, Dennis M. ;

Reid, Ian R. ;

Boonen, Steven ;

Bucci-Rechtweg, Christina ;

Cauley, Jane A. ;

Cosman, Felicia ;

Cummings, Steven R. ;

Hue, Trisha F. ;

Lippuner, Kurt ;

Lakatos, Peter ;

Leung, Ping Chung ;

Man, Zulema ;

Martinez, Ruvie Lou Maria ;

Tan, Monique ;

Ruzycky, Mary Ellen ;

Su, Guoqin ;

Eastell, Richard .

JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (02) :243-254

[5] Ten years' experience with alendronate for osteoporosis in postmenopausal women [J].

Bone, HG ;

Hosking, D ;

Devogelaer, J ;

Tucci, JR ;

Emkey, RD ;

Tonino, RP ;

Rodriguez-Portales, JA ;

Downs, RW ;

Gupta, J ;

Santora, AC ;

Liberman, UA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1189-1199

[6]

Bonnick SL, 2010, MENOPAUSE, V17, P25, DOI [10.1097/gme.0b013e3181e617e6, 10.1097/gme.0b013e3181c617e6]

[7] Effects of hormone therapy on bone mineral density - Results from the postmenopausal estrogen/progestin interventions (PEPI) trial [J].

Bush, TL ;

Wells, HB ;

James, MK ;

BarrettConnor, E ;

Marcus, R ;

Greendale, G ;

Hunsberger, S ;

McGowan, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (17) :1389-1396

[8] Screening for Osteoporosis: US Preventive Services Task Force Recommendation Statement [J].

Calonge, Ned ;

Bibbins-Domingo, Kirsten ;

Cantu, Adelita Gonzales ;

Curry, Susan ;

Dietrich, Allen J. ;

Flores, Glenn ;

Grossman, David ;

Isham, George ;

LeFevre, Michael L. ;

Leipzig, Rosanne M. ;

Melnikow, Joy ;

Melnyk, Bernadette ;

Nicholson, Wanda ;

Reyes, Carolina ;

Schwartz, J. Sanford ;

Wilt, Timothy .

ANNALS OF INTERNAL MEDICINE, 2011, 154 (05) :356-+

[9] Effects of estrogen plus progestin on risk of fracture and bone mineral density - The Women's Health Initiative randomized trial [J].

Cauley, JA ;

Robbins, J ;

Chen, Z ;

Cummings, SR ;

Jackson, RD ;

LaCroix, AZ ;

LeBoff, M ;

Lewis, CE ;

McGowan, J ;

Neuner, J ;

Pettinger, M ;

Stefanick, ML ;

Wactawski-Wende, J ;

Watts, NB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13) :1729-1738

[10] Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 [J].

Compston, J. ;

Bowring, C. ;

Cooper, A. ;

Cooper, C. ;

Davies, C. ;

Francis, R. ;

Kanis, J. A. ;

Marsh, D. ;

McCloskey, E. V. ;

Reid, D. M. ;

Selby, P. .

MATURITAS, 2013, 75 (04) :392-396

← 1 2 3 4 →